Lv41
470 积分 2023-09-13 加入
Exploring using HBsAg to predict interferon treatment course to achieve clinical cure in chronic hepatitis B patients: a clinical study
34分钟前
已完结
Predictive factors for clinical cure in the treatment of HBeAg(−) chronic hepatitis B or compensated cirrhosis: a prospective observational study
38分钟前
已完结
Predictive model for HBsAg clearance rate in chronic hepatitis B patients treated with pegylated interferon α-2b for 48 weeks
48分钟前
已完结
Optimal Treatment Based on Interferon No Longer Makes Clinical Cure of Chronic Hepatitis B Far Away: An Evidence‐Based Review on Emerging Clinical Data
1小时前
已完结
Efficacy of short-term Peg-IFN α-2b treatment in chronic hepatitis B patients with ultra-low HBsAg levels: a retrospective cohort study
1小时前
已完结
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries
1年前
已完结
Switching from entecavir to tenofovir alafenamide for chronic hepatitis B patients with low‐level viraemia
1年前
已完结
HBsAg spontaneous seroclearance in a cohort of HBeAg‐seronegative patients with chronic hepatitis B virus infection
1年前
已完结
Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus
1年前
已完结
HBsAg seroclearance in asymptomatic carriers of high endemic areas: Appreciably high rates during a long-term follow-up
1年前
已完结
皖公网安备34019202002308
